Ferroglobe Reports Results for Third Quarter 2017
Ferroglobe Reports Results for Third Quarter 2017
- Q3 2017 revenue of
$451.6 million , up 6% from$425.8 million in Q2 2017 - Q3 2017 net loss of
$(5.0) million and a diluted loss per share of$(0.02) , down from a net profit of$1.0 million and diluted earnings per share of$0.02 in the prior quarter, driven by tax adjustments/valuation allowances - Q3 2017 adjusted net profit of
$9.2 million , or$0.05 on a fully diluted per share basis, compared to a net profit of$6.0 million , or$0.05 on a fully diluted per share basis in the prior quarter - Q3 2017 reported EBITDA of
$54.3 million , an increase of 48% compared to reported EBITDA of$36.8 million in Q2 2017 - Q3 2017 adjusted EBITDA of
$56.1 million , an increase of 28% compared to$43.9 million adjusted EBITDA in the prior quarter - Maintained strong balance sheet with Q3 2017 net debt of
$394.3 million 1 compared to$434.6 million in Q2 2017 - Results exceeded expectations with strong performance driven by price recovery and volume improvements in both silicon metal and manganese based alloys
In Q3 2017,
Q3 2017 reported EBITDA was
Net sales in Q3 2017 totaled
- The average selling price for silicon metal increased by 5.4% from
$2,210 /MT in Q2 2017 to$2,330 /MT in Q3 2017, a significant improvement driven mainly by the market impact of the ongoing trade cases inthe United States ; - The average selling price for silicon-based alloys increased 3.7% to
$1,645 /MT in the quarter from$1,586 /MT in the prior quarter; - The average selling price for manganese alloys increased 3.1% to
$1,349 /MT in Q3 as compared to$1,308 /MT in the prior quarter; and, -
In addition to these pricing trends,
Ferroglobe continued to realize average sales prices in excess of the index.
In addition to improved pricing, the company also saw stabilization of demand and volumes across its key products. In terms of sales volumes, silicon metal experienced a 0.7% increase quarter-over-quarter, manganese alloys experienced a 14.3% increase quarter-over-quarter and silicon alloys experienced a 5.7% decrease quarter-over-quarter.
____________________________
1 As of
Quarter Ended | Quarter Ended | Quarter Ended | Nine Months Ended | Nine Months Ended | ||||||||||||||
Shipments in metric tons: | ||||||||||||||||||
Silicon Metal | 83,465 | 82,881 | 81,091 | 242,099 | 259,016 | |||||||||||||
Silicon-based Alloys | 66,873 | 70,913 | 69,539 | 212,622 | 218,271 | |||||||||||||
Manganese-based Alloys | 73,642 | 64,403 | 59,368 | 201,745 | 193,985 | |||||||||||||
Total shipments* | 223,980 | 218,197 | 209,998 | 656,466 | 671,272 | |||||||||||||
Quarter Ended | Quarter Ended | Quarter Ended | Nine Months Ended | Nine Months Ended | ||||||||||||||
Average selling price ($/MT): | ||||||||||||||||||
Silicon Metal | ||||||||||||||||||
Silicon-based Alloys | ||||||||||||||||||
Manganese-based Alloys | ||||||||||||||||||
Total* | ||||||||||||||||||
Quarter Ended | Quarter Ended | Quarter Ended | Nine Months Ended | Nine Months Ended | ||||||||||||||
Average selling price ($/lb.): | ||||||||||||||||||
Silicon Metal | ||||||||||||||||||
Silicon-based Alloys | ||||||||||||||||||
Manganese-based Alloys | ||||||||||||||||||
Total* | ||||||||||||||||||
* Excludes by-products and other | ||||||||||||||||||
"Ferroglobe delivered strong performance with quarter-over-quarter earnings growth and improved profitability. The ongoing trade cases in
Strong cash flow generation continues to support liquidity
Working capital decreased by
Ferroglobe's net debt was
Adjusted EBITDA:
Quarter Ended | Quarter Ended | Quarter Ended | Nine Months Ended | Nine Months Ended | |||||||||||||||
(Loss) profit attributable to the parent | $ | (3,347 | ) | 2,859 | (28,523 | ) | (7,042 | ) | (96,460 | ) | |||||||||
Loss attributable to non-controlling interest | (1,640 | ) | (1,859 | ) | (2,545 | ) | (5,060 | ) | (15,836 | ) | |||||||||
Income tax expense (benefit) | 14,364 | (1,949 | ) | (10,158 | ) | 11,201 | (38,419 | ) | |||||||||||
Net finance expense | 14,528 | 14,547 | 6,693 | 42,045 | 21,216 | ||||||||||||||
Financial derivatives loss | 1,823 | 4,071 | - | 5,894 | - | ||||||||||||||
Exchange differences | 1,529 | (7,263 | ) | 876 | (5,714 | ) | 2,880 | ||||||||||||
Depreciation and amortization charges, operating allowances and write-downs | 27,076 | 26,401 | 30,440 | 80,699 | 97,972 | ||||||||||||||
EBITDA | 54,333 | 36,807 | (3,217 | ) | 122,023 | (28,647 | ) | ||||||||||||
Non-controlling interest settlement | - | 1,751 | - | 1,751 | - | ||||||||||||||
Power credit | - | (3,696 | ) | - | (3,696 | ) | - | ||||||||||||
Long lived asset charge due to reclassification of discontinued operations to continuing operations | - | 2,608 | - | 2,608 | - | ||||||||||||||
Accrual of contingent liabilities related to commercial disputes | - | 6,400 | - | 6,400 | - | ||||||||||||||
Impairment loss | - | - | 9,043 | - | 67,630 | ||||||||||||||
Transaction and due diligence expenses | - | - | 111 | - | 7,979 | ||||||||||||||
Business interruption | (1,980 | ) | - | 2,532 | (1,980 | ) | 2,532 | ||||||||||||
Inventory impairment | - | - | 4,330 | - | 4,330 | ||||||||||||||
Step-up valuation adjustment | 3,757 | - | - | 3,757 | - | ||||||||||||||
Globe purchase price allocation adjustments | - | - | - | - | 10,022 | ||||||||||||||
Adjusted EBITDA | $ | 56,110 | 43,870 | 12,799 | 130,863 | 63,846 | |||||||||||||
Adjusted net profit (loss) attributable to
Quarter Ended | Quarter Ended | Quarter Ended | Nine Months Ended | Nine Months Ended | ||||||||||||||||
(Loss) profit attributable to the parent | $ | (3,347 | ) | 2,859 | (28,523 | ) | (7,042 | ) | (96,460 | ) | ||||||||||
Tax rate adjustment | 11,363 | (1,645 | ) | 3,035 | 11,489 | 9,810 | ||||||||||||||
Non-controlling interest settlement | - | 1,191 | - | 1,191 | - | |||||||||||||||
Power credit | - | (2,513 | ) | - | (2,513 | ) | - | |||||||||||||
Long lived asset charge due to reclassification of discontinued operations to continuing operations | - | 1,773 | - | 1,773 | - | |||||||||||||||
Accrual of contingent liabilities related to commercial disputes | - | 4,352 | - | 4,352 | - | |||||||||||||||
Impairment loss | - | - | 6,149 | - | 45,988 | |||||||||||||||
Transaction and due diligence expenses | - | - | 75 | - | 5,426 | |||||||||||||||
Business interruption | (1,346 | ) | - | 1,722 | (1,346 | ) | 1,722 | |||||||||||||
Inventory impairment | - | - | 2,944 | - | 2,944 | |||||||||||||||
Step-up valuation adjustment | 2,555 | - | - | 2,555 | - | |||||||||||||||
Globe purchase price allocation adjustments | - | - | - | - | 6,815 | |||||||||||||||
Adjusted profit (loss) attributable to the parent | $ | 9,225 | 6,017 | (14,598 | ) | 10,459 | (23,755 | ) | ||||||||||||
Adjusted diluted profit (loss) per share:
Quarter Ended | Quarter Ended | Quarter Ended | Nine Months Ended | Nine Months Ended | ||||||||||||||||
Diluted profit (loss) per ordinary share | (0.02 | ) | 0.02 | (0.17 | ) | (0.04 | ) | (0.56 | ) | |||||||||||
Tax rate adjustment | 0.07 | (0.01 | ) | 0.01 | 0.07 | 0.06 | ||||||||||||||
Non-controlling interest settlement | - | 0.01 | - | 0.01 | - | |||||||||||||||
Power credit | - | (0.01 | ) | - | (0.01 | ) | - | |||||||||||||
Long lived asset charge due to reclassification of discontinued operations to continuing operations | - | 0.01 | - | 0.01 | - | |||||||||||||||
Accrual of contingent liabilities related to commercial disputes | - | 0.03 | - | 0.03 | - | |||||||||||||||
Impairment loss | - | - | 0.04 | - | 0.27 | |||||||||||||||
Transaction and due diligence expenses | - | - | - | - | 0.03 | |||||||||||||||
Business interruption | (0.01 | ) | - | 0.01 | (0.01 | ) | 0.01 | |||||||||||||
Inventory impairment | - | - | 0.02 | - | 0.02 | |||||||||||||||
Executive severance | - | - | - | - | - | |||||||||||||||
Step-up valuation adjustment | 0.01 | - | - | 0.01 | - | |||||||||||||||
Globe purchase price allocation adjustments | - | - | - | - | 0.04 | |||||||||||||||
Adjusted diluted profit (loss) per ordinary share | 0.05 | 0.05 | (0.09 | ) | 0.07 | (0.13 | ) | |||||||||||||
Recent developments
The trade cases in
In the ongoing trade cases that
On
The CITT issued its reasons for decision on
We note this decision has no relevance for or impact on the ongoing antidumping and countervailing duty cases in
On
Conference Call
The dial-in number for the call for participants in
About
Forward-Looking Statements
This release contains "forward-looking statements" within the meaning of
Forward-looking statements contained in this press release are based on information presently available to the Company and assumptions that we believe to be reasonable, but are inherently uncertain. As a result,
Forward-looking financial information and other metrics presented herein represent the Company's goals and are not intended as guidance or projections for the periods presented herein or any future periods.
All information in this press release is as of the date of its release. Ferroglobe does not undertake any obligation to update publicly any of the forward-looking statements contained herein to reflect new information, events or circumstances arising after the date of this press release. You should not place undue reliance on any forward-looking statements, which are made only as of the date of this press release.
Non-IFRS Measures
EBITDA, adjusted EBITDA, adjusted diluted profit (loss) per ordinary share and adjusted profit (loss) attributable to the parent are, we believe, pertinent non-IFRS financial metrics that
INVESTOR CONTACT:
Chief Financial Officer
Email: jragan@ferroglobe.com
Unaudited Condensed Consolidated Income Statement | ||||||||||||||||||||
(in thousands of | ||||||||||||||||||||
Quarter Ended | Quarter Ended | Quarter Ended | Nine Months Ended | Nine Months Ended | ||||||||||||||||
Sales | $ | 451,628 | 425,810 | 364,727 | 1,273,475 | 1,186,159 | ||||||||||||||
Cost of sales | (267,364 | ) | (250,279 | ) | (236,631 | ) | (758,781 | ) | (771,238 | ) | ||||||||||
Other operating income | 7,404 | 4,008 | 4,963 | 13,041 | 11,013 | |||||||||||||||
Staff costs | (74,183 | ) | (74,168 | ) | (67,586 | ) | (214,836 | ) | (206,819 | ) | ||||||||||
Other operating expense | (59,741 | ) | (65,009 | ) | (60,490 | ) | (184,874 | ) | (179,805 | ) | ||||||||||
Depreciation and amortization charges, operating allowances and write-downs | (27,076 | ) | (26,401 | ) | (30,440 | ) | (80,699 | ) | (97,972 | ) | ||||||||||
Impairment losses | (98 | ) | - | (9,044 | ) | (98 | ) | (67,631 | ) | |||||||||||
Other gain (loss) | (3,313 | ) | (3,555 | ) | 844 | (5,904 | ) | (326 | ) | |||||||||||
Operating profit (loss) | 27,257 | 10,406 | (33,657 | ) | 41,324 | (126,619 | ) | |||||||||||||
Finance income | 258 | 162 | 548 | 1,215 | 1,233 | |||||||||||||||
Finance expense | (14,786 | ) | (14,709 | ) | (7,241 | ) | (43,260 | ) | (22,449 | ) | ||||||||||
Financial derivatives loss | (1,823 | ) | (4,071 | ) | - | (5,894 | ) | - | ||||||||||||
Exchange differences | (1,529 | ) | 7,263 | (876 | ) | 5,714 | (2,880 | ) | ||||||||||||
Profit (loss) before tax | 9,377 | (949 | ) | (41,226 | ) | (901 | ) | (150,715 | ) | |||||||||||
Income tax (expense) benefit | (14,364 | ) | 1,949 | 10,158 | (11,201 | ) | 38,419 | |||||||||||||
(Loss) profit for the period | (4,987 | ) | 1,000 | (31,068 | ) | (12,102 | ) | (112,296 | ) | |||||||||||
Loss attributable to non-controlling interest | 1,640 | 1,859 | 2,545 | 5,060 | 15,836 | |||||||||||||||
(Loss) profit attributable to the parent | $ | (3,347 | ) | 2,859 | (28,523 | ) | (7,042 | ) | (96,460 | ) | ||||||||||
EBITDA | 54,333 | 36,807 | (3,217 | ) | 122,023 | (28,647 | ) | |||||||||||||
Adjusted EBITDA | 56,110 | 43,870 | 12,799 | 130,863 | 63,846 | |||||||||||||||
Weighted average shares outstanding | ||||||||||||||||||||
Basic | 171,947 | 171,947 | 171,838 | 171,947 | 171,838 | |||||||||||||||
Diluted | 171,947 | 172,047 | 171,838 | 171,947 | 171,838 | |||||||||||||||
(Loss) profit per ordinary share | ||||||||||||||||||||
Basic | (0.02 | ) | 0.02 | (0.17 | ) | (0.04 | ) | (0.56 | ) | |||||||||||
Diluted | (0.02 | ) | 0.02 | (0.17 | ) | (0.04 | ) | (0.56 | ) | |||||||||||
Unaudited Condensed Consolidated Statement of Financial Position | |||||||
(in thousands of | |||||||
| |||||||
2017 | 2017 | 2016 | |||||
ASSETS | |||||||
Non-current assets | |||||||
$ | 234,613 | 232,250 | 230,210 | ||||
Other intangible assets | 59,120 | 60,282 | 62,839 | ||||
Property, plant and equipment | 890,084 | 888,844 | 781,606 | ||||
Non-current financial assets | 6,372 | 6,198 | 5,823 | ||||
Non-current financial assets from related parties | - | - | 9,845 | ||||
Deferred tax assets | 49,463 | 52,214 | 44,950 | ||||
Non-current receivables from related parties | 2,363 | 2,282 | 2,108 | ||||
Other non-current assets | 21,971 | 22,337 | 20,245 | ||||
Total non-current assets | 1,263,986 | 1,264,407 | 1,157,626 | ||||
Current assets | |||||||
Inventories | 353,296 | 337,555 | 316,702 | ||||
Trade and other receivables | 328,056 | 229,703 | 209,406 | ||||
Current receivables from related parties | 3,351 | 3,684 | 11,971 | ||||
Current income tax assets | 7,896 | 11,272 | 19,869 | ||||
Current financial assets | 3,681 | 3,661 | 4,049 | ||||
Other current assets | 12,834 | 12,568 | 9,810 | ||||
Cash and cash equivalents | 189,763 | 183,561 | 196,931 | ||||
Assets and disposal groups classified as held for sale | - | - | 92,937 | ||||
Total current assets | 898,877 | 782,004 | 861,675 | ||||
Total assets | $ | 2,162,863 | 2,046,411 | 2,019,301 | |||
EQUITY AND LIABILITIES | |||||||
Equity | $ | 915,837 | 906,518 | 892,042 | |||
Non-current liabilities | |||||||
Deferred income | 5,077 | 5,960 | 3,949 | ||||
Provisions | 87,490 | 85,029 | 81,957 | ||||
Bank borrowings | - | 62,776 | 179,473 | ||||
Obligations under finance leases | 71,894 | 72,647 | 3,385 | ||||
Debt instruments | 338,772 | 338,202 | - | ||||
Other financial liabilities | 97,560 | 116,492 | 86,467 | ||||
Other non-current liabilities | 2,385 | 2,449 | 5,737 | ||||
Deferred tax liabilities | 143,789 | 144,345 | 139,535 | ||||
Total non-current liabilities | 746,967 | 827,900 | 500,503 | ||||
Current liabilities | |||||||
Provisions | 23,736 | 22,091 | 19,627 | ||||
Bank borrowings * | 146,221 | 1,021 | 241,818 | ||||
Obligations under finance leases | 12,572 | 12,030 | 1,852 | ||||
Debt instruments | 2,738 | 12,537 | - | ||||
Other financial liabilities | 34,375 | 2,460 | 1,592 | ||||
Payables to related parties | 10,466 | 8,813 | 30,738 | ||||
Trade and other payables | 184,244 | 178,602 | 157,706 | ||||
Current income tax liabilities | 8,350 | 4,673 | 961 | ||||
Other current liabilities | 77,357 | 69,766 | 64,780 | ||||
Liabilities associated with assets classified as held for sale | - | - | 107,682 | ||||
Total current liabilities | 500,059 | 311,993 | 626,756 | ||||
Total equity and liabilities | $ | 2,162,863 | 2,046,411 | 2,019,301 | |||
* As of | |||||||
Unaudited Condensed Consolidated Statement of Cash Flows | |||||||||||||||||||||
(in thousands of | |||||||||||||||||||||
Quarter Ended | Quarter Ended | Quarter Ended | Nine Months Ended | Nine Months Ended | |||||||||||||||||
CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||||||||||||||||
(Loss) profit for the period | $ | (4,987 | ) | 1,000 | (31,068 | ) | (12,102 | ) | (112,296 | ) | |||||||||||
Adjustments to reconcile net loss to net cash provided by operating activities: | |||||||||||||||||||||
Income tax expense (benefit) | 14,364 | (1,949 | ) | (10,158 | ) | 11,201 | (38,419 | ) | |||||||||||||
Depreciation and amortization charges, operating allowances and write-downs | 27,076 | 26,401 | 30,440 | 80,699 | 97,972 | ||||||||||||||||
Finance income | (258 | ) | (162 | ) | (548 | ) | (1,215 | ) | (1,233 | ) | |||||||||||
Finance expense | 14,786 | 14,709 | 7,241 | 43,260 | 22,449 | ||||||||||||||||
Financial derivatives loss | 1,823 | 4,071 | - | 5,894 | - | ||||||||||||||||
Exchange differences | 1,529 | (7,263 | ) | 876 | (5,714 | ) | 2,880 | ||||||||||||||
Impairment losses | 98 | - | 9,044 | 98 | 67,631 | ||||||||||||||||
(Gain) loss on disposals of non-current and financial assets | 3,711 | 1,348 | 217 | 4,501 | 408 | ||||||||||||||||
Other adjustments | (364 | ) | 2,208 | 3,269 | 1,438 | 4,248 | |||||||||||||||
Changes in operating assets and liabilities | |||||||||||||||||||||
(Increase) decrease in inventories | (4,372 | ) | (11,943 | ) | 2,135 | (9,207 | ) | 59,831 | |||||||||||||
(Increase) decrease in trade receivables | (90,108 | ) | 9,456 | 17,547 | (76,887 | ) | 71,783 | ||||||||||||||
Increase (Decrease) increase in trade payables | 3,370 | (8,943 | ) | 9,834 | 12,583 | 1,093 | |||||||||||||||
Other* | 6,631 | (506 | ) | (603 | ) | (28,420 | ) | (59,504 | ) | ||||||||||||
Income taxes paid | (3,768 | ) | (3,919 | ) | (8,911 | ) | (9,984 | ) | (20,188 | ) | |||||||||||
Interest paid | (22,249 | ) | (4,378 | ) | (6,837 | ) | (36,356 | ) | (20,306 | ) | |||||||||||
Net cash (used) provided by operating activities | (52,718 | ) | 20,130 | 22,478 | (20,211 | ) | 76,349 | ||||||||||||||
CASH FLOWS FROM INVESTING ACTIVITIES: | |||||||||||||||||||||
Payments due to investments: | |||||||||||||||||||||
Other intangible assets | (88 | ) | - | (2,020 | ) | (498 | ) | (2,543 | ) | ||||||||||||
Property, plant and equipment | (14,692 | ) | (14,319 | ) | (10,805 | ) | (41,373 | ) | (53,289 | ) | |||||||||||
Non-current financial assets | - | - | (411 | ) | (14 | ) | (684 | ) | |||||||||||||
Current financial assets | - | - | 3,988 | - | (9,930 | ) | |||||||||||||||
Disposals: | |||||||||||||||||||||
Current financial assets | - | - | (99 | ) | - | - | |||||||||||||||
Interest received | 54 | 211 | 1,328 | 618 | 2,037 | ||||||||||||||||
Net cash used by investing activities | (14,726 | ) | (14,108 | ) | (8,019 | ) | (41,267 | ) | (64,409 | ) | |||||||||||
CASH FLOWS FROM FINANCING ACTIVITIES: | |||||||||||||||||||||
Dividends paid | - | - | (27,496 | ) | - | (41,243 | ) | ||||||||||||||
Payment for debt issuance costs | (3,210 | ) | (3,078 | ) | - | (16,765 | ) | - | |||||||||||||
Proceeds from debt issuance | - | - | - | 350,000 | - | ||||||||||||||||
Increase/(decrease) in bank borrowings: | |||||||||||||||||||||
Borrowings | 118,468 | 30 | 22,362 | 149,923 | 105,331 | ||||||||||||||||
Payments | (38,296 | ) | (15,300 | ) | (19,623 | ) | (425,976 | ) | (57,698 | ) | |||||||||||
Other amounts paid due to financing activities | (990 | ) | (10,694 | ) | (3,750 | ) | (18,895 | ) | (8,313 | ) | |||||||||||
Net cash provided (used) by financing activities | 75,972 | (29,042 | ) | (28,507 | ) | 38,287 | (1,923 | ) | |||||||||||||
TOTAL NET CASH FLOWS FOR THE PERIOD | 8,528 | (23,020 | ) | (14,048 | ) | (23,191 | ) | 10,017 | |||||||||||||
Beginning balance of cash and cash equivalents | 183,561 | 193,031 | 135,774 | 196,982 | 116,666 | ||||||||||||||||
Exchange differences on cash and cash equivalents in foreign currencies | (2,326 | ) | 13,550 | (2,560 | ) | 15,972 | (7,517 | ) | |||||||||||||
Ending balance of cash and cash equivalents | $ | 189,763 | 183,561 | 119,166 | 189,763 | 119,166 | |||||||||||||||
* Includes the cash outflow impact of the | |||||||||||||||||||||
News Provided by Acquire Media